BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12099074)

  • 1. One million U.S. adults may suffer from psoriatic arthritis.
    Dermatol Nurs; 2002 Jun; 14(3):207-8. PubMed ID: 12099074
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of etanercept in lymphedema associated with psoriatic arthritis.
    Lekpa FK; Economu-Dubosc A; Fevre C; Claudepierre P; Chevalier X
    J Rheumatol; 2009 Jan; 36(1):207-8. PubMed ID: 19208540
    [No Abstract]   [Full Text] [Related]  

  • 3. Etanercept in the treatment of severe, resistant psoriatic arthritis: continued efficacy and changing patterns of use after two years.
    Yazici Y; Erkan D; Lockshin MD
    Clin Exp Rheumatol; 2002; 20(1):115. PubMed ID: 11892697
    [No Abstract]   [Full Text] [Related]  

  • 4. Psoriatic onychopachydermoperiostitis: improvement with etanercept.
    Dans M; Hivnor C; van Voorhees AS
    Br J Dermatol; 2005 Oct; 153(4):858-9. PubMed ID: 16181482
    [No Abstract]   [Full Text] [Related]  

  • 5. No evidence-based practice by biased information from systematic reviews: the case of etanercept and infliximab for the treatment of psoriatic arthritis.
    Corrao S; Puleo A; Pistone G; Calvo L; Scaglione R; Licata G
    Clin Exp Rheumatol; 2008; 26(1):164; author reply 165. PubMed ID: 18328174
    [No Abstract]   [Full Text] [Related]  

  • 6. Psoriatic arthritis patients doing better on infliximab than etanercept.
    Smith N; Gadsby K; Deighton C
    Rheumatology (Oxford); 2007 Apr; 46(4):721-2. PubMed ID: 17314216
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful use of etanercept in acquired angioedema in a patient with psoriatic arthritis.
    Rottem M; Mader R
    J Rheumatol; 2010 Jan; 37(1):209. PubMed ID: 20040647
    [No Abstract]   [Full Text] [Related]  

  • 8. Etanercept is safely used for treating psoriatic arthritis in a patient complicated with type 1 hereditary angioedema.
    Umegaki N; Kira M; Horiuchi T; Itoi S; Tani M; Yokomi A; Tanemura A; Miyahara H; Hatanaka M; Kitamura H; Kitano E; Katayama I
    Mod Rheumatol; 2012 Nov; 22(6):928-30. PubMed ID: 22310967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From wheels to feet: a dramatic response of severe chronic psoriatic arthritis to etanercept.
    ElKayam O; Yaron M; Caspi D
    Ann Rheum Dis; 2000 Oct; 59(10):839. PubMed ID: 11203155
    [No Abstract]   [Full Text] [Related]  

  • 10. Etanercept (Enbrel) -- an update.
    Goffe B
    Skin Therapy Lett; 2004 Dec-2005 Jan; 9(10):1-4, 9. PubMed ID: 15657632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNFalpha inhibition in psoriatic arthritis: cause for hope.
    Zabraniecki L; Fournié B
    Joint Bone Spine; 2001 Mar; 68(2):106-8. PubMed ID: 11324924
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy of psoriasis vulgaris and psoriatic arthritis with etanercept].
    Mrowietz U; Barth J; Boehncke WH; Rosenbach T; Wozel G
    J Dtsch Dermatol Ges; 2005 Jun; 3(6):470-2. PubMed ID: 15892851
    [No Abstract]   [Full Text] [Related]  

  • 13. Biologic therapy in psoriatic arthritis mutilans.
    Peixoto D; Teixeira F; Bogas M; Costa J; Araújo D
    Acta Reumatol Port; 2011; 36(2):189-90. PubMed ID: 21841743
    [No Abstract]   [Full Text] [Related]  

  • 14. Etanercept: a new era in the treatment of psoriatic arthritis.
    Mease PJ
    Am J Manag Care; 2002 Apr; 8(6 Suppl):S181-93. PubMed ID: 11990863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case definition of psoriatic arthritis.
    Taylor WJ; Fellow DE; Helliwell PS
    Lancet; 2000 Dec; 356(9247):2095; author reply 2096. PubMed ID: 11145512
    [No Abstract]   [Full Text] [Related]  

  • 16. Combination of skin, joint and quality of life outcomes with etanercept in psoriasis and psoriatic arthritis in the PRESTA trial.
    Prinz JC; Fitzgerald O; Boggs RI; Foehl J; Robertson D; Pedersen R; Molta CT; Freundlich B
    J Eur Acad Dermatol Venereol; 2011 May; 25(5):559-64. PubMed ID: 20840349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNFalpha therapy in psoriatic arthritis and psoriasis.
    Mease P
    Ann Rheum Dis; 2004 Jul; 63(7):755-8. PubMed ID: 15194567
    [No Abstract]   [Full Text] [Related]  

  • 18. Paradoxical reaction to etanercept: development of pyoderma gangraenosum during therapy of psoriasis arthritis.
    Kowalzick L; Bertolini J; Baumann C; Walther B; Truhm B; Eickenscheidt L
    J Dtsch Dermatol Ges; 2013 May; 11(5):447-9. PubMed ID: 23343137
    [No Abstract]   [Full Text] [Related]  

  • 19. Etanercept plus ciclosporin versus etanercept plus methotrexate for maintaining clinical control over psoriatic arthritis: a randomised pilot study.
    Atzeni F; Boccassini L; Antivalle M; Salaffi F; Sarzi-Puttini P
    Ann Rheum Dis; 2011 Apr; 70(4):712-4. PubMed ID: 20810394
    [No Abstract]   [Full Text] [Related]  

  • 20. Etanercept: an evolving role in psoriasis and psoriatic arthritis.
    Prodanovich S; Ricotti C; Glick BP; Inverardi L; Leonardi CL; Kerdel F
    Am J Clin Dermatol; 2010; 11 Suppl 1():3-9. PubMed ID: 20586498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.